ENFN Historical Earnings image   This ENFN historical earnings page last updated 11/11/2022
ENFN Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/10/20220.04B
Q2 20228/9/20220.04B
Q1 20225/12/20220.03B
Q4 20213/24/20220.03B
Q3 202112/2/20210.03B
ENFN Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202211/10/20220.020
Q2 20228/9/2022-0.030
Q1 20225/12/2022-0.100
Q4 20213/24/20220.010
Q3 202112/2/20210.050
What was the record high ENFN historical earnings result?
In terms of earnings or revenue, what is the best ENFN historical earnings result that Enfusion has ever posted, and when?

✔️Accepted answer: Within our data set, the highest ENFN historical earnings result was set in Q3 2021, when Enfusion posted results of 0.050/share. The most successful revenue quarter within our data set was Q3 2022 when Enfusion reported revenue of 0.04B.

What was the lowest Enfusion historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest ENFN has reported, and when?

✔️Accepted answer: Within our data set, the lowest ENFN historical earnings result was set in Q1 2022, when Enfusion posted results of -0.100/share. The smallest revenue quarter within our data set was Q3 2021 when Enfusion reported revenue of 0.03B.

On this page we presented the ENFN historical earnings date information for Enfusion. Reviewing that ENFN Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2021, when ENFN posted gaap of 0.050/share. Meanwhile the lowest ENFN historical earnings result was in Q1 2022, when ENFN posted gaap of -0.100/share. Moving to Enfusions historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2022 when ENFN reported 0.04B in revenue, while the smallest revenue quarter was Q3 2021 when ENFN reported 0.03B in revenue.

For self directed investors doing their due diligence on ENFN or any other given stock, their research can benefit from looking into all of the Enfusion historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Enfusion historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for ENFN. Thanks for visiting, and the next time you need to research ENFN historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Funds Holding CNFR, Funds Holding FANG, EIDX Insider Buying.

 

ENFN Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.